Multidisciplinary Tumor Board Mucinous Ovarian Neoplasms
Gynecological cancers are the leading causes of cancer morbidity and mortality for women in India. Doctors from MSK in New York partnered with doctors from RCC, Thiruvananthapuram to present two mucinous ovarian neoplasms cases as part of an ongoing multidisciplinary tumor board series.
Unraveling the Challenges: Comprehensive Approach to Management of Oligoprogression in Breast Cancer
Dr. Jasmeet C. Singh (MSK, NY), Dr. Andrew D. Seidman (MSK, NY) and Dr. Atul Batra (AIIMS, India) moderate a discussion with their fellow world-renowned colleagues about the management of oligoprogression in breast cancer.
International Precision Oncology Tumor Board - Targeting the MEK Pathway
Join leading global experts to discover best practices on interpreting results from next-generation genomic sequencing of cancer, and identifying the right drug for the right patient.
International Precision Oncology Tumor Board: MSK & Sir HN Reliance Foundation Hospital: Targeting the BRAF Pathway
The second in an ongoing series led by Dr. Mrinal Gounder of MSK and Dr. Sewanti Limaye of Sir HN Reliance Foundation Hospital in Mumbai, this tumor board focused on the BRAF pathway.
Multidisciplinary Tumor Board on Advanced/Recurrent Endometrial Cancer - MSK & CMC Vellore
Gynecological cancers are the leading causes of cancer morbidity and mortality for women in India. To share expertise, advance research, and improve patient outcomes, Memorial Sloan Kettering Cancer Center (MSK) in New York is excited to present an educational series between MSK and the leading institutions of India. For this particular event, we are honored to partner with CMC Vellore in India.
Surgical Margins in Management of Oral Cancer - MSK & Apollo
Partnering with Apollo Hospital in Mumbai, India the multidisciplinary tumor board on May 19 included presentations on margin assessment, along with case studies on management of early oral cancer as well as locally advanced oral cancer.